CHICAGO — The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday. AbbVie announced the ...
Testosterone replacement therapy, most commonly available as a transdermal gel, is increasingly used to treat men with testosterone deficiency. Although gels provide a convenient, noninvasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback